Variant report

Variant	nsv898763
Chromosome Location	chr12:10514528-10603670
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1870)
CpG islands
(count:855)
Chromatin interactive
region (count:24)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

(count:1870 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:10515922-10516407	K562	blood:	n/a	n/a
2	ARID3A	chr12:10519484-10519894	HepG2	liver:	n/a	n/a
3	ARID3A	chr12:10517306-10518105	HepG2	liver:	n/a	n/a
4	ARID3A	chr12:10536954-10536986	K562	blood:	n/a	n/a
5	ARID3A	chr12:10548121-10548681	HepG2	liver:	n/a	n/a
6	ARID3A	chr12:10563882-10564383	HepG2	liver:	n/a	n/a
7	ARID3A	chr12:10562084-10562332	K562	blood:	n/a	n/a
8	ARID3A	chr12:10592356-10592503	HepG2	liver:	n/a	n/a
9	ATF1	chr12:10515987-10516344	K562	blood:	n/a	n/a
10	ATF1	chr12:10518698-10519024	K562	blood:	n/a	n/a
11	ATF1	chr12:10518006-10518279	K562	blood:	n/a	n/a
12	ATF1	chr12:10562095-10562363	K562	blood:	n/a	n/a
13	ATF2	chr12:10547858-10548386	GM12878	blood:	n/a	n/a
14	ATF2	chr12:10516736-10518064	GM12878	blood:	n/a	n/a
15	ATF2	chr12:10517765-10518225	H1-hESC	embryonic stem cell:	n/a	n/a
16	ATF2	chr12:10515391-10516378	GM12878	blood:	n/a	n/a
17	ATF2	chr12:10517788-10518192	H1-hESC	embryonic stem cell:	n/a	n/a
18	ATF2	chr12:10515378-10516482	GM12878	blood:	n/a	n/a
19	ATF2	chr12:10544776-10545621	GM12878	blood:	n/a	n/a
20	ATF2	chr12:10516513-10517982	GM12878	blood:	n/a	n/a
21	ATF3	chr12:10515933-10516347	K562	blood:	n/a	n/a
22	BACH1	chr12:10517085-10517124	H1-hESC	embryonic stem cell:	n/a	n/a
23	BATF	chr12:10516901-10517786	GM12878	blood:	n/a	n/a
24	BATF	chr12:10598779-10599011	GM12878	blood:	n/a	chr12:10598893-10598904
25	BATF	chr12:10583308-10583579	GM12878	blood:	n/a	chr12:10583461-10583472
26	BCL11A	chr12:10598783-10598965	GM12878	blood:	n/a	n/a
27	BCL11A	chr12:10547875-10548349	GM12878	blood:	n/a	n/a
28	BCL11A	chr12:10516986-10517620	GM12878	blood:	n/a	n/a
29	BCL11A	chr12:10544925-10545336	GM12878	blood:	n/a	n/a
30	BCL11A	chr12:10547793-10548282	GM12878	blood:	n/a	n/a
31	BCL11A	chr12:10517007-10517370	GM12878	blood:	n/a	n/a
32	BCL11A	chr12:10515491-10515913	GM12878	blood:	n/a	n/a
33	BCL11A	chr12:10544909-10545281	GM12878	blood:	n/a	n/a
34	BCL11A	chr12:10583293-10583483	GM12878	blood:	n/a	n/a
35	BCL3	chr12:10515498-10515948	GM12878	blood:	n/a	n/a
36	BCL3	chr12:10592167-10592607	A549	lung:	n/a	n/a
37	BCLAF1	chr12:10516769-10517765	GM12878	blood:	n/a	n/a
38	BCLAF1	chr12:10547846-10548369	GM12878	blood:	n/a	n/a
39	BCLAF1	chr12:10544894-10545448	GM12878	blood:	n/a	n/a
40	BCLAF1	chr12:10544936-10545515	GM12878	blood:	n/a	chr12:10545490-10545499
41	BCLAF1	chr12:10516330-10516752	GM12878	blood:	n/a	n/a
42	BCLAF1	chr12:10516740-10517803	GM12878	blood:	n/a	n/a
43	BHLHE40	chr12:10516495-10517792	K562	blood:	n/a	n/a
44	BHLHE40	chr12:10559410-10559764	GM12878	blood:	n/a	n/a
45	BHLHE40	chr12:10515601-10515915	GM12878	blood:	n/a	n/a
46	BHLHE40	chr12:10547847-10548665	GM12878	blood:	n/a	n/a
47	BHLHE40	chr12:10515999-10516244	K562	blood:	n/a	n/a
48	BHLHE40	chr12:10562058-10562261	K562	blood:	n/a	n/a
49	BHLHE40	chr12:10516861-10517974	GM12878	blood:	n/a	n/a
50	BHLHE40	chr12:10559427-10559772	K562	blood:	n/a	n/a

(count:855 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:10543073-10543123	T-47D	breast:	n/a
2	chr12:10543073-10543123	T-47D	breast:	n/a
3	chr12:10532046-10532096	PrEC	prostate:	n/a
4	chr12:10588483-10588533	HL-60	blood:	n/a
5	chr12:10532046-10532096	RPTEC	kidney:	n/a
6	chr12:10544636-10544686	HNPCEpiC	eye:	n/a
7	chr12:10545083-10545133	GM12891	blood:	n/a
8	chr12:10586130-10586180	HEK293	kidney:	embryo
9	chr12:10583355-10583405	AG10803	skin:	n/a
10	chr12:10545083-10545133	MCF10A-Er-Src	breast:	n/a
11	chr12:10545083-10545133	NB4	blood:	n/a
12	chr12:10544636-10544686	AG10803	skin:	n/a
13	chr12:10525233-10525283	ovcar-3	ovarian:	n/a
14	chr12:10570179-10570229	PANC-1	pancreas:	n/a
15	chr12:10588483-10588533	H1-hESC	embryonic stem cell:	embryo
16	chr12:10532046-10532096	HUVEC	blood vessel:	n/a
17	chr12:10543073-10543123	HIPEpiC	eye:	n/a
18	chr12:10515574-10515624	Jurkat	blood:	n/a
19	chr12:10599740-10599790	Caco-2	colon:	n/a
20	chr12:10515574-10515624	SK-N-SH_RA	brain:	n/a
21	chr12:10515091-10515141	MCF-7	breast:	n/a
22	chr12:10515574-10515624	HRPEpiC	eye:	n/a
23	chr12:10560602-10560652	AG09319	gingival:	n/a
24	chr12:10588483-10588533	GM19239	blood:	n/a
25	chr12:10543073-10543123	H1-hESC	embryonic stem cell:	embryo
26	chr12:10570179-10570229	LNCaP	prostate:	n/a
27	chr12:10545083-10545133	LNCaP	prostate:	n/a
28	chr12:10570179-10570229	U87	brain:	n/a
29	chr12:10570179-10570229	NHDF-neo	bronchial:	n/a
30	chr12:10586130-10586180	LNCaP	prostate:	n/a
31	chr12:10583355-10583405	HRPEpiC	eye:	n/a
32	chr12:10586130-10586180	HL-60	blood:	n/a
33	chr12:10560602-10560652	HepG2	liver:	n/a
34	chr12:10586130-10586180	SK-N-MC	brain:	n/a
35	chr12:10543073-10543123	NB4	blood:	n/a
36	chr12:10515574-10515624	NT2-D1	testis:	n/a
37	chr12:10525233-10525283	HCF	heart:	n/a
38	chr12:10515574-10515624	Caco-2	colon:	n/a
39	chr12:10588483-10588533	PFSK-1	brain:	n/a
40	chr12:10544636-10544686	HRCEpiC	kidney:	n/a
41	chr12:10532046-10532096	HCT-116	colon:	n/a
42	chr12:10560602-10560652	ECC-1	luminal epithelium:	n/a
43	chr12:10588483-10588533	AG09319	gingival:	n/a
44	chr12:10515574-10515624	HEEpiC	esophagus:	n/a
45	chr12:10545083-10545133	HCM	heart:	n/a
46	chr12:10583355-10583405	NH-A	brain:	n/a
47	chr12:10599740-10599790	Jurkat	blood:	n/a
48	chr12:10515091-10515141	NHDF-neo	bronchial:	n/a
49	chr12:10516240-10516290	SKMC	muscle:	n/a
50	chr12:10532046-10532096	CMK	blood:	n/a

(count:24 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:28974955..28975586-chr12:10563608..10564342,2	Hela-S3	cervix:
2	chr12:10519323..10520144-chr12:10902384..10903013,2	MCF-7	breast:
3	chr12:10547736..10550018-chr12:10555798..10557891,2	MCF-7	breast:
4	chr12:10527378..10530229-chr12:10546803..10548399,2	K562	blood:
5	chr12:10572017..10574193-chr12:10588542..10590731,2	MCF-7	breast:
6	chr12:10520202..10521817-chr12:10526312..10528193,2	K562	blood:
7	chr12:10534850..10537741-chr12:10540764..10542364,2	MCF-7	breast:
8	chr12:10548044..10548696-chr9:117267865..117268396,2	Hela-S3	cervix:
9	chr12:10527378..10530229-chr12:10546803..10548399,2	K562	blood:
10	chr12:10515701..10519228-chr12:10526352..10529377,4	K562	blood:
11	chr12:10561211..10561774-chr17:76182659..76183234,2	Hela-S3	cervix:
12	chr12:10554334..10554872-chr16:81477760..81478703,2	Hela-S3	cervix:
13	chr12:10537029..10538774-chr12:10541549..10544546,2	K562	blood:
14	chr12:10516092..10519058-chr12:10537972..10540241,2	K562	blood:
15	chr12:10563346..10565218-chr12:11316267..11318781,2	K562	blood:
16	chr12:10572017..10574193-chr12:10588542..10590731,2	MCF-7	breast:
17	chr12:10520202..10521817-chr12:10526312..10528193,2	K562	blood:
18	chr12:10515701..10517485-chr12:10526352..10529351,3	K562	blood:
19	chr12:10528733..10530247-chr12:10762165..10764402,2	K562	blood:
20	chr12:10559960..10560793-chrX:131351678..131352452,2	Hela-S3	cervix:
21	chr12:10514090..10517702-chr12:10563594..10568036,4	K562	blood:
22	chr12:10518506..10519182-chr16:20688297..20688797,2	HCT-116	colon:
23	chr12:10536735..10538905-chr12:10543028..10545121,2	MCF-7	breast:
24	chr12:10547736..10550018-chr12:10555798..10557891,2	MCF-7	breast:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KLRD1-1	chr12:10516368-10516632	ENSG00000245648
2	lnc-KLRD1-1	chr12:10526634-10526735	ENSG00000245648
3	lnc-EIF2S3L.1-6	chr12:10601202-10602083	l_610_chr12:10597245-10602083_whiteBloodCell
4	lnc-KLRD1-1	chr12:10548778-10551105	ENSG00000245648
5	lnc-KLRD1-1	chr12:10532301-10532435	ENSG00000245648
6	lnc-EIF2S3L.1-6	chr12:10597246-10597382	l_610_chr12:10597245-10602083_whiteBloodCell

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	KLRK1	hsa-miR-9-5p	chr12:10525600-10525624

Variant related genes	Relation type
KLRC3	TF binding region
KLRC4	TF binding region
KLRC4-KLRK1	TF binding region
ENSG00000245648	TF binding region
ENSG00000255641	TF binding region
KLRC2	TF binding region
KLRK1	TF binding region
KLRC1	TF binding region
ENSG00000256155	TF binding region
KLRC3	CpG island
KLRC4	CpG island
KLRC4-KLRK1	CpG island
ENSG00000245648	CpG island
ENSG00000255641	CpG island
KLRC2	CpG island
KLRK1	CpG island
KLRC1	CpG island
ENSG00000256155	CpG island
ENSG00000255641	chromatin interactions
ENSG00000245648	chromatin interactions
ENSG00000213809	chromatin interactions
ENSG00000205810	chromatin interactions
ENSG00000167900	chromatin interactions
ENSG00000256888	chromatin interactions
ENSG00000205809	chromatin interactions
ENSG00000123728	chromatin interactions
ENSG00000270103	chromatin interactions
KIAA1967	miRNA target sites
SMAD4	miRNA target sites
ESR1	miRNA target sites

Extended variants
information (count: 3714 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:3714 , 50 per page) page: 1 2 3 4 5 6 7 ... 75

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7305635	chr12:10514528-10514529	Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs7139147	chr12:10514555-10514556	Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs79106463	chr12:10514556-10514557	Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs541445104	chr12:10514574-10514575	Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs577676825	chr12:10514583-10514584	Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs113577453	chr12:10514617-10514618	Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs143715323	chr12:10514618-10514619	Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs528728266	chr12:10514716-10514717	Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs112206088	chr12:10514768-10514769	Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs191521262	chr12:10514802-10514803	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs549357670	chr12:10514809-10514810	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs148105843	chr12:10514983-10514984	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs182843437	chr12:10514989-10514990	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs34347461	chr12:10514993-10514994	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs188208233	chr12:10515002-10515003	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs11053773	chr12:10515006-10515007	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs113881704	chr12:10515024-10515025	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs111931101	chr12:10515032-10515033	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs534774866	chr12:10515104-10515105	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
20	rs546736398	chr12:10515117-10515118	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
21	rs114015893	chr12:10515136-10515137	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
22	rs191547745	chr12:10515142-10515143	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs10743887	chr12:10515151-10515152	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
24	rs10845122	chr12:10515166-10515167	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs376419185	chr12:10515175-10515176	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs371156593	chr12:10515176-10515177	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs373668531	chr12:10515177-10515178	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs201336841	chr12:10515188-10515189	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs202099725	chr12:10515189-10515190	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs575366980	chr12:10515192-10515193	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs111309516	chr12:10515194-10515195	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs113576116	chr12:10515207-10515208	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs546437140	chr12:10515248-10515249	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs577713386	chr12:10515259-10515260	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs11053774	chr12:10515289-10515290	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs540228074	chr12:10515294-10515295	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs147523384	chr12:10515329-10515330	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs573636921	chr12:10515348-10515349	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs542681107	chr12:10515366-10515367	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs140090634	chr12:10515371-10515372	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs183742313	chr12:10515372-10515373	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs11053775	chr12:10515377-10515378	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
43	rs187924717	chr12:10515387-10515388	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs533195343	chr12:10515390-10515391	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs10772269	chr12:10515394-10515395	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs553601323	chr12:10515411-10515412	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs60925438	chr12:10515412-10515413	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs115360333	chr12:10515413-10515414	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs371434594	chr12:10515421-10515422	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs59873659	chr12:10515424-10515425	Flanking Active TSS Weak transcription Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Hepatocellular carcinoma	16750200	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21611746	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Squamous cell cancer	19607727	CNVD
Prostate cancer	16573809	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Acute myeloid leukemia	17268525	CNVD
Acute monocytic leukemia	16498392	CNVD
Prostate cancer	16461572	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:1729 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:10507400-10515800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr12:10508000-10515200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr12:10511600-10516400	Weak transcription	Gastric	stomach
4	chr12:10511800-10516200	Weak transcription	Thymus	Thymus
5	chr12:10512200-10515200	Weak transcription	Primary T killer memory cells from peripheral blood	blood
6	chr12:10512800-10515000	Weak transcription	Primary B cells from cord blood	blood
7	chr12:10512800-10515200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
8	chr12:10513000-10514800	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr12:10513000-10515600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
10	chr12:10513000-10516400	Enhancers	HUES64 Cell Line	embryonic stem cell
11	chr12:10513400-10514600	Enhancers	Primary T cells fromperipheralblood	blood
12	chr12:10513400-10514800	Enhancers	Cortex derived primary cultured neurospheres	brain
13	chr12:10513400-10515400	Enhancers	HMEC	breast
14	chr12:10513400-10516200	Enhancers	Placenta Amnion	Placenta Amnion
15	chr12:10513400-10517000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr12:10513600-10514600	Enhancers	Dnd41	blood
17	chr12:10513600-10515200	Enhancers	Fetal Kidney	kidney
18	chr12:10513600-10516200	Enhancers	Breast Myoepithelial Primary Cells	Breast
19	chr12:10513600-10516400	Enhancers	Fetal Lung	lung
20	chr12:10513600-10516400	Enhancers	Osteobl	bone
21	chr12:10513600-10516600	Weak transcription	H9 Cell Line	embryonic stem cell
22	chr12:10513600-10516600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr12:10513600-10516600	Weak transcription	Aorta	Aorta
24	chr12:10513800-10514600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr12:10513800-10514800	Enhancers	Muscle Satellite Cultured Cells	--
26	chr12:10513800-10515400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
27	chr12:10513800-10515600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr12:10514000-10514600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
29	chr12:10514000-10514800	Flanking Active TSS	K562	blood
30	chr12:10514000-10515000	Weak transcription	Fetal Stomach	stomach
31	chr12:10514000-10515000	Weak transcription	Fetal Thymus	thymus
32	chr12:10514000-10515400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
33	chr12:10514000-10516200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr12:10514000-10516200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr12:10514000-10516400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr12:10514000-10516400	Weak transcription	Pancreas	Pancrea
37	chr12:10514000-10516600	Enhancers	iPS-18 Cell Line	embryonic stem cell
38	chr12:10514000-10516800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
39	chr12:10514000-10517200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
40	chr12:10514200-10514600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
41	chr12:10514200-10514600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
42	chr12:10514200-10514600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
43	chr12:10514200-10514600	Enhancers	Brain Angular Gyrus	brain
44	chr12:10514200-10514600	Flanking Active TSS	Hela-S3	cervix
45	chr12:10514200-10514800	Enhancers	A549	lung
46	chr12:10514200-10515000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
47	chr12:10514200-10515200	Enhancers	ES-I3 Cell Line	embryonic stem cell
48	chr12:10514200-10515200	Weak transcription	Primary B cells from peripheral blood	blood
49	chr12:10514200-10515200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
50	chr12:10514200-10515600	Enhancers	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links